SION – sionna therapeutics, inc. (US:NASDAQ)

News

Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com